Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
m336
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Neutralization
Human
IgG1, kappa
S41
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
D12
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
3A1
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
REGN3051
Human betacoronavirus 2c EMC/2012
FCM, Neutralization, SPR
Human
IgG1, kappa
2E6#
Human betacoronavirus 2c EMC/2012
ELISA, Neutralization
Human
IgG1, kappa
4C2
Middle East respiratory syndrome-related coronavirus (MERS-CoV)
ELISA, Neutralization
Mouse
IgG2a, kappa
1.6C7
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, IF, Neutralization
Mouse
IgG2a, kappa
G2
E. coli
K9N638
Tyr16-Gly193
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV)